Results 161 to 170 of about 87,208 (292)
Factors influencing decision-making between surgery and chemoradiotherapy for esophageal carcinoma from the JCOG0502 [PDF]
Shun Yamamoto +18 more
openalex +1 more source
Using a machine learning–based approach in a multi‐institutional prospective cohort, we identified a robust miRNA signature that demonstrated high diagnostic accuracy for esophageal squamous cell carcinoma. Our 57‐miRNA panel achieved an AUC of 0.90 in the proof‐of‐concept cohort and 0.85 in an independent validation cohort, with a sensitivity of 84 ...
Tatsuro Murano +14 more
wiley +1 more source
The impact of sequential chemoradiotherapy versus concurrent chemoradiotherapy on prognosis in adjuvant treatment after radical hysterectomy for cervical cancer. [PDF]
Ma Y, Shi S.
europepmc +1 more source
Correction to: Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer [PDF]
Olarn Roengvoraphoj +9 more
openalex +1 more source
FB23‐2 potentiates cisplatin's antitumor efficacy in head and neck squamous cell carcinoma by disrupting XPF/ERCC1 complex assembly and nuclear translocation, thereby suppressing DNA damage repair machinery and amplifying platinum‐induced tumor cell death.
Yaoqi Jiang +7 more
wiley +1 more source
Chuanfeng Zhang, Zhen Guo, Zhao Jing Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang, 310013, People’s Republic of ChinaCorrespondence: Zhao Jing, Department of Oncology, Zhejiang Hospital, No.
Zhang C, Guo Z, Jing Z
doaj
Neoadjuvant chemoradiotherapy versus neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma with three-field lymph node dissection. [PDF]
Zhuang F +7 more
europepmc +1 more source
Upon chemotherapy, a subset of cancer cells enters a senescent state, referred to as TIS. When IAP antagonists are administered, TIS cells are selectively eliminated through TNFα‐independent apoptosis. TNFα secreted by TIS cancer cells may also act in a paracrine manner to enhance extrinsic apoptosis in neighboring non‐senescent cancer cells.
Hiroaki Ochiiwa +7 more
wiley +1 more source
Distinct immune cell dynamics associated with immune-related adverse events during combined chemoradiation and immune checkpoint inhibitor therapy. [PDF]
Zhang L +13 more
europepmc +1 more source

